N
BIIB icon

Nuveen’s Biogen BIIB Stock Holding History

Nuveen’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,300
Closed -$4K – 3377
2021
Q1 		$4K Sell
15,300
-15,500
-50% -$4.18M ﹤0.01% 3339
2020
Q4 		$8K Buy
+30,800
New +$7.95M ﹤0.01% 3258
2020
Q3 		– Sell
-30,800
Closed -$8K – 3296
2020
Q2 		$8K Buy
+30,800
New +$9.26M ﹤0.01% 3214

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen's BIIB Position: Q1 2026 in Review

Nuveen reduced its Biogen (BIIB) stake by 4.5% in Q1 2026, selling an estimated $3.08M and leaving 358,838 shares worth $65.8M. The position accounts for 0.02% of the portfolio, ranked #532.

Nuveen first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $371M in Q4 2019. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Nuveen held 358,838 shares of Biogen worth $65.8M as of Q1 2026.
  • Nuveen sold 16,719 Biogen shares in Q1 2026, an estimated $3.08M.
  • Biogen made up 0.02% of Nuveen's portfolio in Q1 2026, its #532 holding.
  • Nuveen first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Nuveen's Biogen position peaked at $371M in Q4 2019.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.